CapForce Inc - Company Profile
Powered by 
All the sales intelligence you need on CapForce Inc in one solution.
- Save hours of research time with a comprehensive
Sales Intelligence Solution.
- Understand how CapForce Inc fits into your total
addressable market and Ideal Customer Profile.
- Gain competitive edge with triggers that tell you
when and how to engage with CapForce Inc.
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
CapForce Inc (CapForce) is a precision medicine company focused on developing and commercialising molecular diagnostics and bioinformatics to combat infectious diseases. The company's primary activities involve creating highly multiplexed syndromic molecular panels to address antimicrobial resistance (AMR), improve antibiotic stewardship, and reduce the spread of multidrug-resistant microorganisms (MDROs). CapForce's product portfolio includes Unyvero, Acuitas AMR Gene Panel, and the ARES Technology Platform, which encompasses ARESdb, NGS technology, and AI-powered bioinformatics solutions such as ARESiss, ARESid, ARESasp, and AREScloud. Capforce's products and services are primarily used by clinicians to obtain rapid and actionable information about life-threatening infections, thereby improving patient outcomes and mitigating the spread of MDROs. CapForce is headquartered in Rockville, Maryland, the US.
Headquarters
United States of America
Address
23219 Stringtown Road, Suite 300, Clarksburg, Maryland, 20871
Website
capforce.opgen.com
Telephone
1 301 8699683
No of Employees
1
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
CFOR (OTC)
Revenue (2024)
$5.2M
52%
(2024 vs 2023)
EPS
XYZ
Net Income (2024)
XYZ
136.7%
(2024 vs 2023)
Market Cap*
$112.6M
Net Profit Margin (2024)
XYZ
124.2%
(2024 vs 2023)
* As of and is in US$
CapForce Inc premium industry data and analytics
Products and Services
| Products | Services |
|---|---|
| Technology: | Surveillance Services |
| ARES Technology | Sequencing |
| NGS technology | ARESid |
| XYZ | XYZ |
| XYZ | XYZ |
| XYZ | XYZ |
History
History section provides information on new products, mergers, acquisitions, expansions, approvals, and many more key events.
| Year | Event | Description |
|---|---|---|
| 2026 | Corporate Changes/Expansions | In February, the company changed its name to CapForce Inc. |
| 2023 | Contracts/Agreements | In August, Curetis GmbH signed an extended and continued research and development agreement with FIND for the development of an AMR assay and Unyvero A30 cartridge for AMR detection. |
| 2023 | Contracts/Agreements | In April, the company entered into an agreement with Fisher Healthcare for distribution of OpGen’s Unyvero A50 platform and in vitro diagnostic (IVD) tests for bacterial pneumonia. |
Competitor Comparison
| Key Parameters | CapForce Inc | bioMerieux SA | Silence Therapeutics Plc | C4 Therapeutics Inc | XOMA Royalty Corp |
|---|---|---|---|---|---|
| Headquarters | United States of America | France | United Kingdom | United States of America | United States of America |
| City | Clarksburg | Craponne | London | Watertown | Emeryville |
| State/Province | Maryland | Rhone Alpes | England | Massachusetts | California |
| No. of Employees | 1 | 15,226 | 115 | 110 | 13 |
| Entity Type | Public | Public | Public | Public | Public |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| John Tan Honjian | Chairman; Director | Executive Board | 2024 | 34 |
| Christian-Laurent Bonte | Chief Executive Officer | Senior Management | 2025 | 47 |
| Mohd Azham Azudin | Chief Operating Officer | Senior Management | - | 52 |
| Syed Johan Bin Syed Mohd | Chief Technology Officer | Senior Management | - | 37 |
| David E. Lazar | President | Senior Management | 2024 | 33 |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2026 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer